NO20076478L - Substituerte oksadiazolderivater som positive allosteriske modulatorer av metabotrope glutamatreseptorer - Google Patents

Substituerte oksadiazolderivater som positive allosteriske modulatorer av metabotrope glutamatreseptorer

Info

Publication number
NO20076478L
NO20076478L NO20076478A NO20076478A NO20076478L NO 20076478 L NO20076478 L NO 20076478L NO 20076478 A NO20076478 A NO 20076478A NO 20076478 A NO20076478 A NO 20076478A NO 20076478 L NO20076478 L NO 20076478L
Authority
NO
Norway
Prior art keywords
oxadiazole derivatives
metabotropic glutamate
positive allosteric
glutamate receptors
allosteric modulators
Prior art date
Application number
NO20076478A
Other languages
English (en)
Inventor
Giovanni Palombi
Sonia-Maria Poli
Emmanuel Le Poul
Marco Farina
Stefania Gagliardi
Vincent Mutel
Jean-Philippe Rocher
Original Assignee
Addex Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0510138A external-priority patent/GB0510138D0/en
Priority claimed from GBGB0601709.9A external-priority patent/GB0601709D0/en
Application filed by Addex Pharma Sa filed Critical Addex Pharma Sa
Publication of NO20076478L publication Critical patent/NO20076478L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Den foreliggende oppfinnelse vedrører nye forbindelser som er oksadiazol-derivater med formel (I) hvori B, P, Q, W, Ri og R2 er definert i beskrivelsen. Forbindelsene ifølge oppfinnelsen er anvendelige ved forebygging eller behandling av sentrale eller perifere sykdommer så vel som andre sykdommer som blir modulert ved mGluR5-reseptorer. (I)
NO20076478A 2005-05-18 2007-12-17 Substituerte oksadiazolderivater som positive allosteriske modulatorer av metabotrope glutamatreseptorer NO20076478L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0510138A GB0510138D0 (en) 2005-05-18 2005-05-18 Novel compounds A4
GBGB0601709.9A GB0601709D0 (en) 2006-01-27 2006-01-27 Novel compounds A4
PCT/IB2006/001881 WO2006123255A2 (en) 2005-05-18 2006-05-17 Substituted oxadiazole derivatives as positive allosteric modulators of metabotropic glutamate receptors

Publications (1)

Publication Number Publication Date
NO20076478L true NO20076478L (no) 2008-01-28

Family

ID=37431638

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076478A NO20076478L (no) 2005-05-18 2007-12-17 Substituerte oksadiazolderivater som positive allosteriske modulatorer av metabotrope glutamatreseptorer

Country Status (13)

Country Link
US (1) US20090215822A1 (no)
EP (1) EP1893606A2 (no)
JP (1) JP2008540635A (no)
KR (1) KR20080027463A (no)
AU (1) AU2006248655A1 (no)
BR (1) BRPI0611423A2 (no)
CA (1) CA2608014A1 (no)
EA (1) EA015813B1 (no)
IL (1) IL187186A0 (no)
MX (1) MX2007014444A (no)
NO (1) NO20076478L (no)
NZ (1) NZ564254A (no)
WO (1) WO2006123255A2 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0510142D0 (en) * 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds A1
GB0510139D0 (en) * 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B1
GB0510140D0 (en) * 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B2
GB0510141D0 (en) 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B3
US7807706B2 (en) 2005-08-12 2010-10-05 Astrazeneca Ab Metabotropic glutamate-receptor-potentiating isoindolones
GB0622202D0 (en) * 2006-11-07 2006-12-20 Addex Pharmaceuticals Sa Novel compounds
TWI417100B (zh) * 2007-06-07 2013-12-01 Astrazeneca Ab 二唑衍生物及其作為代謝型麩胺酸受體增效劑-８４２之用途
TW200911255A (en) * 2007-06-07 2009-03-16 Astrazeneca Ab Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators-841
US7790760B2 (en) 2008-06-06 2010-09-07 Astrazeneca Ab Metabotropic glutamate receptor isoxazole ligands and their use as potentiators 286
MX360330B (es) * 2008-07-29 2018-10-30 Bial Portela & Ca Sa Regimen de administracion para nitrocatecoles.
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
US20100222381A1 (en) 2009-02-27 2010-09-02 Hariprasad Vankayalapati Cyclopentathiophene/cyclohexathiophene DNA methyltransferase inhibitors
AU2010239253A1 (en) * 2009-04-23 2011-11-24 Merck Sharp & Dohme Corp. 2-alkyl piperidine mGluR5 receptor modulators
US8772301B2 (en) 2009-12-18 2014-07-08 Sunovion Pharmaceuticals, Inc. Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
WO2011092293A2 (en) 2010-02-01 2011-08-04 Novartis Ag Cyclohexyl amide derivatives as crf receptor antagonists
AR080055A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de pirazolo-[5,1-b]-oxazol como antagonistas de los receptores de crf -1
JP5748777B2 (ja) 2010-02-02 2015-07-15 ノバルティス アーゲー Ｃｒｆ受容体アンタゴニストとしてのシクロヘキシルアミド誘導体
EP2632469A2 (en) * 2010-10-25 2013-09-04 Merck Sharp & Dohme Corp. Tricyclic mglur5 receptor modulators
WO2016065584A1 (en) * 2014-10-30 2016-05-06 Merck Sharp & Dohme Corp. Piperidine oxadiazole and thiadiazole orexin receptor antagonists
WO2016153023A1 (ja) * 2015-03-25 2016-09-29 国立研究開発法人国立長寿医療研究センター 新規オキサジアゾール誘導体及びこれを含有する医薬
WO2022069953A1 (en) * 2020-09-29 2022-04-07 Ranjith Siddaraj Synthesis and characterization of (s)-3-(5- fluoropyridin-2-yl)-5-(piperidin-3-yl)-l,2,4-oxadiazole derivatives and their secretory phospholipase a2 (spla2) inhibitor activity

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966748A (en) * 1975-05-08 1976-06-29 American Cyanamid Company Para-fluorophenyl-N-heterocyclic substituted butanes
EP1536790A2 (en) * 2002-08-09 2005-06-08 AstraZeneca AB Oxadiazoles as modulators of metabotropic glutamate receptor-5
WO2004087653A2 (en) * 2003-04-03 2004-10-14 Merck & Co., Inc. 4-ring imidazole derivatives as modulators of metabotropic glutamate receptor-5
GB0325956D0 (en) * 2003-11-06 2003-12-10 Addex Pharmaceuticals Sa Novel compounds
EP1716143A1 (en) * 2004-02-18 2006-11-02 AstraZeneca AB Polyheterocyclic compounds and their use as metabotropic glutamate receptor antagonists
GB0510143D0 (en) * 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds A1
GB0510140D0 (en) * 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B2
GB0510142D0 (en) * 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds A1
GB0510141D0 (en) * 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B3
GB0510139D0 (en) * 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B1
GB0622202D0 (en) * 2006-11-07 2006-12-20 Addex Pharmaceuticals Sa Novel compounds

Also Published As

Publication number Publication date
EP1893606A2 (en) 2008-03-05
IL187186A0 (en) 2008-02-09
KR20080027463A (ko) 2008-03-27
WO2006123255A2 (en) 2006-11-23
MX2007014444A (es) 2008-04-21
US20090215822A1 (en) 2009-08-27
AU2006248655A1 (en) 2006-11-23
JP2008540635A (ja) 2008-11-20
NZ564254A (en) 2011-04-29
CA2608014A1 (en) 2006-11-23
EA015813B1 (ru) 2011-12-30
BRPI0611423A2 (pt) 2010-09-08
WO2006123255A3 (en) 2007-03-29
EA200702469A1 (ru) 2008-06-30

Similar Documents

Publication Publication Date Title
NO20076478L (no) Substituerte oksadiazolderivater som positive allosteriske modulatorer av metabotrope glutamatreseptorer
NO20076479L (no) Nye oksadiazolderivater og anvendelse derav som positive allosteriske metabotropiske modulatorer av glutamatreseptorer
NO20076477L (no) Nye heterosykliske forbindelser som positive allosteriske modulatorer av metabotrope glutamatreseptorer
EA200702470A1 (ru) Производные пиррола в качестве положительных аллостерических модуляторов метаботропных глутаматных рецепторов
ATE493397T1 (de) Neuartige tetrazolderivate als positive allosterische modulatoren von metabotropen glutamatrezeptoren
NO20074275L (no) 2- (4-okso-4H-kinazolin-3-yl) acetamider og deres anvendelse som Vasopressin-V3-antagonister
NO20063599L (no) Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister
NO20070606L (no) Inhibitorer av IAP
NO20073663L (no) Tiazol-4-karboksamid-derivater som mGluR5 antagonister
NO20082346L (no) Hydrazonderivater og anvendelser derav
EA201070143A1 (ru) Новые гетероароматические производные и их использование в качестве положительных аллостерических модуляторов метаботропных глутаматных рецепторов
EA201000050A1 (ru) Замещенные бициклолактамные соединения
NO20091553L (no) Fenylderivater og deres anvendelse som immunmodulatorer
EA200870521A1 (ru) Замещенные спироциклические антагонисты cgrp-рецепторов
ATE430744T1 (de) Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
NO20070249L (no) Pyrrazolo-pyrimidin derivater
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
NO20092286L (no) Nitrogenhaldige heterosykliske forbindelser og anvendelse derav
NO20081217L (no) Nye benzotiazolonderivater
NO20083584L (no) Bensoyl-piperidin derivater som 5HT2/D3 modulatorer
WO2008036652A3 (en) Amidines as modulators of indoleamine 2,3-dioxygenase
NO20060195L (no) Kinolylamidderivater som CCR-5-antagonister
NO20064325L (no) Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes
NO20082096L (no) Azaindol-2-karboksamidderivativer
EA200601295A1 (ru) Производные 1,3-диоксана и их аналоги, применимые для лечения i.a. ожирения и диабета

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application